ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
ASKA Pharmaceutical Holdings Co Ltd
Cash Paid for Dividends
ASKA Pharmaceutical Holdings Co Ltd
Cash Paid for Dividends Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Paid for Dividends | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
|
Cash Paid for Dividends
-¥1.3B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash Paid for Dividends
-¥312.9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-8%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash Paid for Dividends
-¥128.5B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-10%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash Paid for Dividends
-¥71B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash Paid for Dividends
-¥299.4B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-25%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Cash Paid for Dividends
-¥136.1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-7%
|
|
ASKA Pharmaceutical Holdings Co Ltd
Glance View
ASKA Pharmaceutical Holdings Co., Ltd. engages in the management of its group companies which are involved in the manufacture and sale of pharmaceuticals, quasi-drugs, food, veterinary drugs, feeds, feed additives, and medical devices. The company is headquartered in Minato-Ku, Tokyo-To. The company went IPO on 2021-04-01. The firm mainly operates in two business segments. The Pharmaceutical segment is mainly engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the manufacture of veterinary drugs, the provision of clinical testing services, the outsourcing of testing services, the purchase and sale of medical equipment, as well as the sale of health foods.
See Also
What is ASKA Pharmaceutical Holdings Co Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-1.3B
JPY
Based on the financial report for Mar 31, 2025, ASKA Pharmaceutical Holdings Co Ltd's Cash Paid for Dividends amounts to -1.3B JPY.
What is ASKA Pharmaceutical Holdings Co Ltd's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 5Y
-26%
Over the last year, the Cash Paid for Dividends growth was -61%. The average annual Cash Paid for Dividends growth rates for ASKA Pharmaceutical Holdings Co Ltd have been -47% over the past three years , -26% over the past five years .
